HomeIndustriesHealthcareLLY's Zepbound to treat Sleep Apnea, QCOM Tops ARM in Court, Honda/Nissan Merger Talks

LLY's Zepbound to treat Sleep Apnea, QCOM Tops ARM in Court, Honda/Nissan Merger Talks

Obesity drugmaker Eli Lilly (LLY) rises after Zepbound gets FDA approval for sleep apnea treatment. Meanwhile, Honda (HMC) and Nissan (NSANY) have begun merger discussions to potentially become the world's 3rd largest automaker. And, Qualcomm (QCOM) prevails in a legal dispute over Arm Holdings (ARM). George Tsilis provides insight on the morning's early headlines.

Morning Trade Live

23 Dec 2024

SHARE

ON AIR
8:30 pm
Market On Close
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
8:00 am
Market Overtime
8:30 am
Market On Close
education
10:00 am
Your First Trade
education
10:30 am
Your First Trade
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Liz Ann Live
REPLAY
8:00 pm
Market Overtime
REPLAY
ON AIR
8:30 pm
Market On Close
REPLAY
education
10:00 pm
Liz Ann Live
REPLAY
10:30 pm
The Wrap
REPLAY

Schwab Network's Newsletters

Daily insights for every investor